Fulcrum Therapeutics earnings were -$9.7M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest FULC earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$16.6M, down 23.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, FULC reported annual earnings of -$9.7M, with -90% growth. The next FULC earnings date is May 12, 2025.
Fulcrum Therapeutics Earnings Reports & History FAQ
What were Fulcrum Therapeutics's earnings last quarter?
On FULC's earnings call on Invalid Date, Fulcrum Therapeutics (NASDAQ: FULC) reported Q4 2024 earnings per share (EPS) of -$0.27, up 32.5% year over year. Total FULC earnings for the quarter were -$16.57 million. In the same quarter last year, Fulcrum Therapeutics's earnings per share (EPS) was -$0.40.
The next FULC earnings date is Invalid Date. Add FULC to your watchlist to be reminded of Fulcrum Therapeutics's next earnings date.
What was FULC's earnings growth in the past year?
As of Fulcrum Therapeutics's earnings date in Invalid Date, Fulcrum Therapeutics's earnings has grown year over year. FULC earnings in the past year totalled -$9.73 million.
Is Fulcrum Therapeutics profitable or losing money?
As of the last Fulcrum Therapeutics earnings report, Fulcrum Therapeutics is currently losing money. Fulcrum Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$9.73 million, a 90.01% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.